Merlin immunoreactivity fails to predict neurofibromatosis type 2 mutations in human meningiomas. Tollefsen SE, Meta R, Solheim O, Mjones P, et al. J Neuropathol Exp Neurol 2025 May 30:nlaf058. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Tollefsen SE, Meta R, Solheim O, Mjones P, et al. Merlin immunoreactivity fails to predict neurofibromatosis type 2 mutations in human meningiomas. J Neuropathol Exp Neurol 2025 May 30:nlaf058. doi: 10.1093.
PMID: 40447281